# Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the AMIC Study

> **NCT06020716** · PHASE4 · RECRUITING · sponsor: **Helse Stavanger HF** · enrollment: 350 (estimated)

## Conditions studied

- Protracted Bacterial Bronchitis

## Interventions

- **DRUG:** Amoxicillin-Clavulanate 400 Mg-57 Mg/5 mL Oral Powder for Reconstitution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06020716
- **Lead sponsor:** Helse Stavanger HF
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-16
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06020716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06020716, "Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the AMIC Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06020716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*